Method of treating cancer using a combination of quinoline derivative and antibody
US-2026097030-A1 · Apr 9, 2026 · US
This page is not indexed by search engines while we improve data quality.
Chia Tai Tianqing Pharmaceutical Group Co Ltd patents in 2026
Chia Tai Tianqing Pharmaceutical Group Co Ltd was listed as an assignee on 11 patent publications in 2026.
| Metric | Value |
|---|---|
| Company | Chia Tai Tianqing Pharmaceutical Group Co Ltd |
| Year | 2026 |
| Patents | 11 |
Patents
Representative publications for Chia Tai Tianqing Pharmaceutical Group Co Ltd in 2026.
Compound containing multi-fused ring structure
US-2026098037-A1 · Apr 9, 2026 · US
Fused tricyclic derivative and pharmaceutical application thereof
US-12590082-B2 · Mar 31, 2026 · US
Anti-siglec-15 antibody and use thereof
US-2026070974-A1 · Mar 12, 2026 · US
Preparation method for CDK4/6 inhibitor
US-12570633-B2 · Mar 10, 2026 · US
Top CPC classifications
Most common classification codes for Chia Tai Tianqing Pharmaceutical Group Co Ltd in 2026.
| CPC | Patents |
|---|---|
| A61P35/00 | 8 |
| C07D471/04 | 5 |
| A61K2039/505 | 3 |
| A61K31/4709 | 3 |
| C07B2200/13 | 3 |
Related pages
Navigate to parent entity pages.